Cancer-Related Systemic Inflammation: The Challenges and Therapeutic Opportunities for Personalized Medicine.

about

Inflammation: Treatment Progress and Limitations.Influence of Inflammation in the Process of T Lymphocyte Differentiation: Proliferative, Metabolic, and Oxidative Changes.

P2860

Q47819096-EED4B1BA-7F4E-4F55-AEA3-B445E18E64D0 Q51733559-58E2AE97-8587-4322-8309-5FE97510105C

P2860

Cancer-Related Systemic Inflammation: The Challenges and Therapeutic Opportunities for Personalized Medicine.

Item

http://www.wikidata.org/entity/Q39429983

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Cancer-Related Systemic Inflam ...... ies for Personalized Medicine.

@en

Cancer-Related Systemic Inflam ...... ies for Personalized Medicine.

@nl

type

Item

label

Cancer-Related Systemic Inflam ...... ies for Personalized Medicine.

@en

Cancer-Related Systemic Inflam ...... ies for Personalized Medicine.

@nl

prefLabel

Cancer-Related Systemic Inflam ...... ies for Personalized Medicine.

@en

Cancer-Related Systemic Inflam ...... ies for Personalized Medicine.

@nl

P1476

Cancer-Related Systemic Inflam ...... ies for Personalized Medicine.

@en

P2093

Connie I Diakos

http://www.w3.org/2001/XMLSchema#string

Diana Shinko

http://www.w3.org/2001/XMLSchema#string

Kellie A Charles

http://www.w3.org/2001/XMLSchema#string

P2860

The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function

Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies

Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Improving cancer immunotherapy by targeting the STATe of MDSCs

Effects of statins on cancer mortality and progression: A systematic review and meta-analysis of 95 cohorts including 1,111,407 individuals.

TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy.

Hepatic cytochrome P450 3A drug metabolism is reduced in cancer patients who have an acute-phase response.

The potential of statins as part of anti-cancer treatment.

Myeloid derived suppressor cells - a new therapeutic target in the treatment of cancer.

P304

599-610

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CPT.789

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P50

Stephen J Clarke

P577

2017-07-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28699186

http://www.w3.org/2001/XMLSchema#string

P921

inflammation

Cancer-Related Systemic Inflammation: The Challenges and Therapeutic Opportunities for Personalized Medicine.

about

P2860

P2860

Cancer-Related Systemic Inflammation: The Challenges and Therapeutic Opportunities for Personalized Medicine.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921